312
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Trends in cannabis-related attitudes and behaviors among cannabis-using adolescent and young adult outpatients following medical cannabis legalization in Massachusetts

, MPHORCID Icon, , MD, MPH, , MD, MPH & , PhD
 

Abstract

Background: Among youth already using cannabis, legalization of medical cannabis may influence cannabis-related attitudes and behaviors, including increasing access through use of someone else’s medical cannabis (diversion). Objective: To examine cannabis-related attitudes and behaviors (including diverted cannabis use) in cannabis-using youth in the four years following medical cannabis legalization. Additionally, we investigated characteristics of youth who used vs. did not use diverted medical cannabis. Methods: Data were collected in Boston from 2013 (when medical cannabis legislation took effect in Massachusetts) through 2016 (when recreational cannabis use became legal in Massachusetts). Cannabis-using youth (age 13–24) presenting to an outpatient adolescent substance use treatment program (ASUTP) or recruited for an adolescent medicine clinic study (AMCS) completed a confidential survey on demographic characteristics and cannabis use behaviors and attitudes. We used multiple logistic regression to analyze changes in attitudes and behaviors over three years versus the reference year (2013), controlling for demographics. We used chi-square to compare characteristics of youth reporting use of diverted medical cannabis versus those not. Results: The sample included 273 cannabis-using youth (ASUTP n = 203, AMCS n = 70; 2013 n = 67, 2014 n = 67, 2015 n = 77, 2016 n = 62). Mean ± SD age was 18.2 ± 2.5 years, 32% were female, 58% were White non-Hispanic, and 70% had college-graduate parents. In 2013, most youth reported that cannabis was easy to obtain (97.9%), and that occasional cannabis use had “no” or “slight” risk of harm (89.4%), with little change across years. In 2016, 44% of youth reported using someone else’s medical cannabis, versus 15% in 2013 (aOR 4.66, 95% CI 1.81, 11.95). Youth using diverted medical cannabis had higher likelihood of reporting riding with a driver, or driving themselves, after cannabis use (both p < .01). Conclusion: Among at-risk youth in Massachusetts, use of diverted medical cannabis increased after medical cannabis legalization, and those using diverted medical cannabis reported higher risk for cannabis-related traffic injury.

Acknowledgements

The authors would like to acknowledge the patients who provided data and made this study possible. We extend our thanks to Julie Lunstead and the rest of the adolescent substance use treatment program team, as well as Bea Duvert and the rest of the adolescent medicine clinic study team.

Author contributions

MO conducted data analysis, and with SKH, led the writing of this manuscript. SL and LS provided critical feedback and contributions to the manuscript. SL and LS directed participant enrollment and data collection.

Disclosure statement

None of the authors report a conflict of interest. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of Boston Children’s Hospital, Harvard Medical School, or any of its affiliates.

Additional information

Funding

This study was supported by the National Institute on Drug Abuse grants R34DA030535 (LAS) and 1R44DA046262-02 (MO, SKH), from the National Institute on Alcohol Abuse and Alcoholism by grant 1R01AA027253-01A1 (MO, SKH), and from the Maternal and Child Health Bureau of the U.S. Department of Health and Human Services by grant T71NC0009 (MO, LAS, SKH). This information or content and conclusions are those of the authors and should not be construed as the official position or policy of, nor should any endorsements be inferred by HHS or the U.S. Government. No funding organization was involved in any aspect of study design, implementation, or data analysis and interpretation, nor in the preparation, review, or approval of the manuscript for publication.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.